This episode will recap updates from the 2023 ASCO Annual Meeting regarding the abstract on comprehensive genomic profiling for non-small cell lung cancer (NSCLC). Join Dr. Vivek Subbiah, Chief of Early Drug Development at the Sarah Cannon Research Institute in Nashville, Tennessee, to learn more.
Mariya Rozenblit, MDPeer
- Project Oncology®
The Role of PARP Inhibitors in Metastatic Breast Cancer